Nanobiotix S.A. American Depositary Shares is a cutting-edge biotechnology company specializing in the development of nanomedicines for the treatment of cancer. With a revolutionary approach that leverages nanoparticles to enhance the efficacy of radiation therapy, Nanobiotix is poised to redefine the field of oncology and potentially improve patient outcomes.
